 |
Sodium phenylacetate/sodium benzoate 10%/10% Injection |
|---|---|
| Trade Name | Ammonul(R) |
| Orphan Indication | Hepatic encephalopathy |
| USA Market Approval | USA |
| USA Designation Date | 2005-06-03 00:00:00 |
| Sponsor | Ucyclyd Pharma, Inc.;7720 N. Dobson Road;Scottsdale, Arizona, 85256 |
